Payden & Rygel Investment Group Abb Vie Inc. Transaction History
Payden & Rygel Investment Group
- $2.12 Billion
- Q1 2024
A detailed history of Payden & Rygel Investment Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Payden & Rygel Investment Group holds 5,010 shares of ABBV stock, worth $837,922. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,010
Previous 5,010
-0.0%
Holding current value
$837,922
Previous $747,000
22.09%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,653Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$28.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$23.9 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.57 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.04 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $296B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...